Asia Pacific Musculoskeletal Disorders Drugs Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Parenteral and Oral), By Drug Type (Analgesics, DMARDs, Corticosteroids), By Country and Growth Forecast, 2023 - 2029

The Asia Pacific Musculoskeletal Disorders Drugs Market would witness market growth of 5.1% CAGR during the forecast period (2023-2029).

Rising healthcare costs and demand for amyotrophic lateral sclerosis pharmaceuticals are providing growth opportunities for the market. The healthcare industry in emergent economies is expanding at a rapid rate due to the growing demand for enhanced healthcare services and the government's substantial investments to improve healthcare infrastructure. In addition, E-commerce (electronic commerce) has become a crucial instrument for small and large businesses around the region due to the increasing preference of consumers for online shopping over conventional purchasing methods, which is increasing the sales of these products and further supports market expansion.

Musculoskeletal conditions can be treated with a variety of approaches, such as taking painkillers, engaging in physical therapy, or even undergoing surgical procedures, but the most popular among them is the use of medications. On the other hand, there is a demand for novel and improved treatments that are more efficient and cause fewer adverse effects. This is where the industry for medicines to treat musculoskeletal diseases comes into play.

The average life expectancy in Japan has been rising, making it one of the top countries in the world for long life expectancy. The average life expectancy was 87.32 years for women and 81.25 years for males as of 2018. By 2065, it is anticipated that men's life expectancy will be 84.95 years and women's will be 91.35 years. The proportion of adults 65 and older has also been increasing and is now the highest in the world. In 2019, it was 28.4; by 2036, it should be 33.35; by 2065, it should be 38.4. Since musculoskeletal disorders are typically more common in older persons, the growing geriatric population and the government's approach to ensuring the welfare of old age population, will increase the demand and purchasing power of the population in the region, which will drive the market growth in APAC.

The China market dominated the Asia Pacific Musculoskeletal Disorders Drugs Market by Country in 2022 and would continue to be a dominant market till 2029; thereby, achieving a market value of $8,837.1 Million by 2029. The Japan market is registering a CAGR of 4.5% during (2023 - 2029). Additionally, The India market would showcase a CAGR of 5.8% during (2023 - 2029).

Based on Distribution Channel, the market is segmented into Drug Stores & Retail Pharmacies, Hospital Pharmacies and Online Providers. Based on Route of Administration, the market is segmented into Parenteral and Oral. Based on Drug Type, the market is segmented into Analgesics, DMARDs, Corticosteroids and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

Free Valuable Insights: The Worldwide Musculoskeletal Disorders Drugs Market is Projected to reach USD 109.4 Billion by 2029, at a CAGR of 4.2%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AbbVie, Inc., Amgen, Inc., Eli Lilly And Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson, Merck & Co., Inc., Novartis AG, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., and UCB S.A.

Scope of the Study

Market Segments Covered in the Report:

By Distribution Channel

• Drug Stores & Retail Pharmacies
• Hospital Pharmacies
• Online Providers

By Route of Administration

• Parenteral
• Oral

By Drug Type

• Analgesics
• DMARDs
• Corticosteroids
• Others

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

• AbbVie, Inc.
• Amgen, Inc.
• Eli Lilly And Company
• F. Hoffmann-La Roche Ltd.
• Johnson & Johnson
• Merck & Co., Inc.
• Novartis AG
• Pfizer, Inc.
• Teva Pharmaceutical Industries Ltd.
• UCB S.A.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Musculoskeletal Disorders Drugs Market, by Distribution Channel
1.4.2 Asia Pacific Musculoskeletal Disorders Drugs Market, by Route of Administration
1.4.3 Asia Pacific Musculoskeletal Disorders Drugs Market, by Drug Type
1.4.4 Asia Pacific Musculoskeletal Disorders Drugs Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Geographical Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)

Chapter 4. Asia Pacific Musculoskeletal Disorders Drugs Market by Distribution Channel
4.1 Asia Pacific Drug Stores & Retail Pharmacies Market by Country
4.2 Asia Pacific Hospital Pharmacies Market by Country
4.3 Asia Pacific Online Providers Market by Country

Chapter 5. Asia Pacific Musculoskeletal Disorders Drugs Market by Route of Administration
5.1 Asia Pacific Parenteral Market by Country
5.2 Asia Pacific Oral Market by Country

Chapter 6. Asia Pacific Musculoskeletal Disorders Drugs Market by Drug Type
6.1 Asia Pacific Analgesics Market by Country
6.2 Asia Pacific DMARDs Market by Country
6.3 Asia Pacific Corticosteroids Market by Country
6.4 Asia Pacific Others Market by Country

Chapter 7. Asia Pacific Musculoskeletal Disorders Drugs Market by Country
7.1 China Musculoskeletal Disorders Drugs Market
7.1.1 China Musculoskeletal Disorders Drugs Market by Distribution Channel
7.1.2 China Musculoskeletal Disorders Drugs Market by Route of Administration
7.1.3 China Musculoskeletal Disorders Drugs Market by Drug Type
7.2 Japan Musculoskeletal Disorders Drugs Market
7.2.1 Japan Musculoskeletal Disorders Drugs Market by Distribution Channel
7.2.2 Japan Musculoskeletal Disorders Drugs Market by Route of Administration
7.2.3 Japan Musculoskeletal Disorders Drugs Market by Drug Type
7.3 India Musculoskeletal Disorders Drugs Market
7.3.1 India Musculoskeletal Disorders Drugs Market by Distribution Channel
7.3.2 India Musculoskeletal Disorders Drugs Market by Route of Administration
7.3.3 India Musculoskeletal Disorders Drugs Market by Drug Type
7.4 South Korea Musculoskeletal Disorders Drugs Market
7.4.1 South Korea Musculoskeletal Disorders Drugs Market by Distribution Channel
7.4.2 South Korea Musculoskeletal Disorders Drugs Market by Route of Administration
7.4.3 South Korea Musculoskeletal Disorders Drugs Market by Drug Type
7.5 Singapore Musculoskeletal Disorders Drugs Market
7.5.1 Singapore Musculoskeletal Disorders Drugs Market by Distribution Channel
7.5.2 Singapore Musculoskeletal Disorders Drugs Market by Route of Administration
7.5.3 Singapore Musculoskeletal Disorders Drugs Market by Drug Type
7.6 Malaysia Musculoskeletal Disorders Drugs Market
7.6.1 Malaysia Musculoskeletal Disorders Drugs Market by Distribution Channel
7.6.2 Malaysia Musculoskeletal Disorders Drugs Market by Route of Administration
7.6.3 Malaysia Musculoskeletal Disorders Drugs Market by Drug Type
7.7 Rest of Asia Pacific Musculoskeletal Disorders Drugs Market
7.7.1 Rest of Asia Pacific Musculoskeletal Disorders Drugs Market by Distribution Channel
7.7.2 Rest of Asia Pacific Musculoskeletal Disorders Drugs Market by Route of Administration
7.7.3 Rest of Asia Pacific Musculoskeletal Disorders Drugs Market by Drug Type

Chapter 8. Company Profiles
8.1 Johnson & Johnson
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental &Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.6 SWOT Analysis
8.2 Pfizer, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional & Segmental Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Acquisition and Mergers:
8.3 AbbVie, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Approvals and Trials:
8.3.5.2 Acquisition and Mergers:
8.3.5.3 Geographical Expansions:
8.4 UCB S.A.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Acquisition and Mergers:
8.5 Amgen, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Acquisition and Mergers:
8.6 Eli Lilly And Company
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expenses
8.7 F. Hoffmann-La Roche Ltd.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.8 Merck & Co., Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.9 Novartis AG
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.10. Teva Pharmaceutical Industries Ltd.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses

TABLE 1 Asia Pacific Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 2 Asia Pacific Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Musculoskeletal Disorders Drugs Market
TABLE 4 geographical expansions – Musculoskeletal Disorders Drugs Market
TABLE 5 Acquisition and Mergers– Musculoskeletal Disorders Drugs Market
TABLE 6 Approvals and trials – Musculoskeletal Disorders Drugs Market
TABLE 7 Asia Pacific Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 8 Asia Pacific Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 9 Asia Pacific Drug Stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 10 Asia Pacific Drug Stores & Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 11 Asia Pacific Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 12 Asia Pacific Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 13 Asia Pacific Online Providers Market by Country, 2019 - 2022, USD Million
TABLE 14 Asia Pacific Online Providers Market by Country, 2023 - 2029, USD Million
TABLE 15 Asia Pacific Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 16 Asia Pacific Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 17 Asia Pacific Parenteral Market by Country, 2019 - 2022, USD Million
TABLE 18 Asia Pacific Parenteral Market by Country, 2023 - 2029, USD Million
TABLE 19 Asia Pacific Oral Market by Country, 2019 - 2022, USD Million
TABLE 20 Asia Pacific Oral Market by Country, 2023 - 2029, USD Million
TABLE 21 Asia Pacific Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 22 Asia Pacific Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 23 Asia Pacific Analgesics Market by Country, 2019 - 2022, USD Million
TABLE 24 Asia Pacific Analgesics Market by Country, 2023 - 2029, USD Million
TABLE 25 Asia Pacific DMARDs Market by Country, 2019 - 2022, USD Million
TABLE 26 Asia Pacific DMARDs Market by Country, 2023 - 2029, USD Million
TABLE 27 Asia Pacific Corticosteroids Market by Country, 2019 - 2022, USD Million
TABLE 28 Asia Pacific Corticosteroids Market by Country, 2023 - 2029, USD Million
TABLE 29 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 30 Asia Pacific Others Market by Country, 2023 - 2029, USD Million
TABLE 31 Asia Pacific Musculoskeletal Disorders Drugs Market by Country, 2019 - 2022, USD Million
TABLE 32 Asia Pacific Musculoskeletal Disorders Drugs Market by Country, 2023 - 2029, USD Million
TABLE 33 China Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 34 China Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 35 China Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 36 China Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 37 China Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 38 China Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 39 China Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 40 China Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 41 Japan Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 42 Japan Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 43 Japan Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 44 Japan Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 45 Japan Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 46 Japan Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 47 Japan Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 48 Japan Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 49 India Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 50 India Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 51 India Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 52 India Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 53 India Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 54 India Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 55 India Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 56 India Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 57 South Korea Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 58 South Korea Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 59 South Korea Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 60 South Korea Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 61 South Korea Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 62 South Korea Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 63 South Korea Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 64 South Korea Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 65 Singapore Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 66 Singapore Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 67 Singapore Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 68 Singapore Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 69 Singapore Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 70 Singapore Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 71 Singapore Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 72 Singapore Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 73 Malaysia Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 74 Malaysia Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 75 Malaysia Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 76 Malaysia Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 77 Malaysia Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 78 Malaysia Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 79 Malaysia Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 80 Malaysia Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 81 Rest of Asia Pacific Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 82 Rest of Asia Pacific Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 83 Rest of Asia Pacific Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 84 Rest of Asia Pacific Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 85 Rest of Asia Pacific Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 86 Rest of Asia Pacific Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 87 Rest of Asia Pacific Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 88 Rest of Asia Pacific Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 89 Key information –Johnson & Johnson
TABLE 90 Key Information – Pfizer, Inc.
TABLE 91 Key information – AbbVie, Inc.
TABLE 92 Key Information – UCB S.A.
TABLE 93 Key Information – Amgen, Inc.
TABLE 94 Key Information – Eli Lilly And Company
TABLE 95 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 96 KEY INFORMATION - Merck & Co., Inc.
TABLE 97 Key Information – Novartis AG
TABLE 98 Key Information – Teva Pharmaceuticals Industries Ltd.

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 4 Asia Pacific Musculoskeletal Disorders Drugs Market Share by Distribution Channel, 2022
FIG 5 Asia Pacific Musculoskeletal Disorders Drugs Market Share by Distribution Channel, 2029
FIG 6 Asia Pacific Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2029, USD Million
FIG 7 Asia Pacific Musculoskeletal Disorders Drugs Market Share by Route of Administration, 2022
FIG 8 Asia Pacific Musculoskeletal Disorders Drugs Market Share by Route of Administration, 2029
FIG 9 Asia Pacific Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2029, USD Million
FIG 10 Asia Pacific Musculoskeletal Disorders Drugs Market Share by Drug Type, 2022
FIG 11 Asia Pacific Musculoskeletal Disorders Drugs Market Share by Drug Type, 2029
FIG 12 Asia Pacific Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2029, USD Million
FIG 13 Asia Pacific Musculoskeletal Disorders Drugs Market Share by Country, 2022
FIG 14 Asia Pacific Musculoskeletal Disorders Drugs Market Share by Country, 2029
FIG 15 Asia Pacific Musculoskeletal Disorders Drugs Market by Country, 2019 - 2029, USD Million
FIG 16 SWOT analysis: Johnson & Johnson
FIG 17 Recent strategies and developments: Pfizer, Inc.
FIG 18 Recent strategies and developments: AbbVie, Inc.